Adage Capital Partners
SIOX

Adage Capital Partners’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Adage Capital Partners’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-125,000
Closed -$305K – 813
2020
Q1 		$305K Hold
125,000
– – ﹤0.01% 711
2019
Q4 		$640K Hold
125,000
– – ﹤0.01% 690
2019
Q3 		$808K Hold
125,000
– – ﹤0.01% 690
2019
Q2 		$779K Hold
125,000
– – ﹤0.01% 686
2019
Q1 		$1.33M Hold
125,000
– – ﹤0.01% 656
2018
Q4 		$996K Hold
125,000
– – ﹤0.01% 682
2018
Q3 		$2.42M Hold
125,000
– – 0.01% 669
2018
Q2 		$2.26M Buy
+125,000
New +$1.84M 0.01% 690

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return